Carpentier-Edwards Aortic Porcine Bioprosthesis

Product catalog summary

Overview: Edwards Lifesciences' porcine valves are designed with advanced technology and manufacturing processes to set industry standards. The Carpentier-Edwards valves incorporate the patented XenoLogiX Treatment, proven fixation technology, specialized construction, a compliant sewing ring, and an Elgiloy stent.

Key Features:

XenoLogiX Treatment: This patented treatment significantly reduces calcification, as demonstrated in animal studies, although long-term patient data is not yet available.
Fixation Technology: The original fixation process minimizes collagen waveform alterations and enhances leaflet compliance.
Specialized Construction: The asymmetrical stent aligns with natural porcine valve geometry, preventing orifice obstruction.
Compliant Sewing Ring: The aortic design is scalloped for annulus conformity, while the mitral design is broad and flat for secure implantation.
Elgiloy Stent: This flexible material reduces tissue stress and enhances spring efficiency.

Product Models:

Aortic Model 2625: Proven durability for over 15 years in patients older than 70 years.
Mitral Model 6625: Recommended for patients over 70 years for mitral valve replacement.

Specifications: The document provides detailed dimensions for both aortic and mitral models, including mounting diameter, graft mounting diameter, profile height, and external sewing ring diameter, all in millimeters.

Recommendations: The Carpentier-Edwards Bioprosthesis is recommended for aortic valve replacement in patients over 70 years and for mitral valve replacement in the same age group.

Contact Information: Edwards Lifesciences provides contact details for their offices in the USA, Canada, Switzerland, and Japan.

Catalog excerpts

Carpentier-Edwards Aortic Porcine Bioprosthesis-1

Carpentier-Edwards Bioprosthesis Edwards Lifesciences’ porcine valves combine rigorous tissue selection, fixation technology and advanced manufacturing components that have set the industry standard. Our Carpentier-Edwards valves feature: New Patented Edwards XenoLogiX Treatment – Significantly reduced calcification in rat and sheep implant studies. 1,2 * Proven Fixation Technology – Original fixation process that remains the foundation of tissue preservation today. – Minimizes alterations in the collagen waveform and increases leaflet compliance Specialized Construction – Asymmetrical stent conforms to the natural porcine valve geometry. – Obstruction of the orifice is prevented by sewing the muscle shelf into the stent wall. Compliant Sewing Ring – Aortic – scalloped design conforms to the contoured shape of the annulus. – Mitral – broad flat design facilitates secure implant onto the annulus. Elgiloy Stent – Flexible material minimizes tissue stress. – Superior spring efficiency reduces creep. *No clinical data are available which evaluate the long-term impact of the XenoLogiX treatment in patients.

Open the catalog to page 1

Carpentier-Edwards Aortic Porcine Bioprosthesis-2

Carpentier-Edwards Bioprosthesis Aortic Model 2625 and Mitral Model 6625 Proven 15 year Durability in Patients > 70 years.3 89% Mitral Actuarial Freedom (%) from Structural Valve Deterioration Actuarial Freedom (%) from Structural Valve Deterioration ”The [Carpentier-Edwards Bioprosthesis] is recommended for aortic valve replacement for patients older than 70 years and for 4 patients 61-70 (when extended longevity is not anticipated) and for mitral valve replacement for patients older than 70 years. “ Specifications Significant dimensions in millimeters (nominal values) Edwards TRUE-SIZE Aortic...

Open the catalog to page 2